Loading data for GRML — first visit, this takes a few seconds.
Greenland Mines Ltd (GRML): cotización, análisis y datos
Valor intrínseco
Pronóstico del analista
Previsiones bursátiles →Últimos resultados
| Reportado | Vs. estimación | Cambio interanual | |
|---|---|---|---|
| Ingresos | — | n/a | n/a |
| EPS | — | n/a | n/a |
Métricas
- Precio de compra
- 4.62
- Ingresos (TTM)
- n/a
- Beneficio neto (TTM)
- -21.8M
- 2.48
- -6.85
- n/a
- n/a
- P/B (TTM)
- 0.18
- P/S (TTM)
- n/a
- Fecha de resultados
- n/a
- Precio de venta
- 5
- Volumen
- 372,396
- Volumen medio (20D)
- 342,426
- Abierto
- 3.25
- Anterior Cerrar
- 3.26
- Rango del día
- 3.07 - 3.26
- Rango de 52 semanas
- 2.99 - 37.00
- analista
- n/a
- Precio objetivo
- n/a
- Dividendos
- n/a
- Fecha ex dividendo
- n/a
Acerca de Greenland Mines Ltd
Ver perfil →Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.
Industria Other Precious Metals & Mining
Sector Basic Materials
IPO Fecha Apr 29, 2022
Empleados 5
Bolsa de Valores NasdaqCM
Símbolo bursátil GRML
Sitio web https://greenlandmines.com